Piezo proteins are homotrimeric ion channels that play major roles in normal and pathological 25 mechanotransduction signaling in mammalian organisms. 
Introduction 38
Piezo proteins are very large (~1MDa) trimeric mechanosensitive ion channels (Fig 1a) which 39 transduce various forms of mechanical stimuli such as shear stress and membrane stretch into 40 important biological signals. In mammals, only two Piezo isoforms named Piezo1-2 have been 41
identified. In spite of their recent discovery, these isoforms have been implicated in a 42 bewildering number of mechanotransduction processes including touch sensation(1-3), 43
proprioception(4), hearing(5), vascular(6, 7) and brain development(8), blood flow sensing(9), 44 osmotic homeostasis(10) and epithelium regulation (11, 12) . Both gain-of-functions and loss-of-45
functions Piezo mutations are associated with human diseases such as xerocytosis (13, 14, 10, 46 15), arthrogryposis (16) (17) (18) (19) (20) (21) (22) and lymphedema(23). Recent studies suggest Piezo channels may also 47 play important roles in other conditions such as sleep apnea (24) and visceral pain (25) . 48 An avenue to treat these diseases would be to correct Piezo channel activity with small 49 molecule agonists and/or antagonists. On the other hand, the availability of selective Piezo 50 modulators would allow us to precisely determine the contribution of each Piezo isoform to 51 complex physiological functions. Unfortunately, the current pharmacology of Piezo channels is 52 extremely limited, with a single Piezo1-selective small molecule agonist named Yoda1(26) (Fig 53 1b) and no known isoform-selective inhibitors. Hence, understanding how Yoda1 selectively 54 binds and activates Piezo1 is a key step to rationally design new small molecule modulators with 55 high selectivity. 56
Yoda1 was recently identified using a simultaneous high-throughput agonist screening on 57 both Piezo1 and 2 isoforms. Although Piezo2 shares more than 65% of its primary amino acid 58 sequence with Piezo1, Yoda1 possesses strict Piezo1 selectivity with no measurable modulatory 59 effects on Piezo2 activity. The activation of Piezo1 by Yoda1 originates from the binding of 60 Yoda1 to one or more unknown binding site(s) on the Piezo1 channel(26). Based on these 61 observations, we have generated Piezo1-Piezo2 chimeras to identify a minimal protein region 62 responsible for Yoda1 binding selectivity. By characterizing hybrid channels containing wild-63 type (WT) and Yoda1-insensitive Piezo1 subunits, we further show that the binding of Yoda1 to 64 a single subunit is sufficient for activation of the trimeric channel. 65 66 67
Results

68
Molecular determinants for Yoda1 selectivity 69
The purified Piezo1 channel reconstituted in artificial bilayer remains . 70
Hence, the Piezo1 protein possesses an endogenous agonist Yoda1 binding site that enables 71 channel activation. The strict Piezo1-selectivity exhibited by Yoda1 must then originate from 72 amino acid differences between the Piezo1 and Piezo2 primary sequence. Since chimeras 73 between evolutionary-distant Piezo homologs remain functional(27), we reasoned that chimeras 74 between mouse Piezo1 (mPiezo1) and mouse Piezo2 (mPiezo2) will yield functioning proteins 75 with altered Yoda1-sensitivity. Since Yoda1 stabilize the open pore conformation in absence of 76 mechanical stimulation(26), we reasoned that the Yoda1 binding site is likely located near the 77 pore in the C-terminal region. We thus designed three C-terminal chimeras and named them by 78 the residue number after which the C-terminal sequence is from mPiezo2 (i.e. Ch1961, Ch2063 79 and Ch2456, Fig 1c and Supplementary Fig 1) . The C-terminal chimeras were expressed into 80 HEK293T cells and characterized using a fluorescence assay based on the calcium-sensitive 81 organic dye Fluo8-AM (Fig 1d) . A variant of this assay was previously used to characterize 82 Yoda1 sensitivity of Piezo homologs and disease variants(26). The chimeras Ch2063 and 2456 83 exhibit concentration-dependent fluorescence responses similar to WT mPiezo1 (Fig 1e) . In 84 contrast, Ch1961 was totally insensitive to Yoda1 in the range of concentrations tested, similar to 85 the Yoda1-insensitive mPiezo2. We independently confirmed the ability of the three C-terminal 86 chimeras to respond to mechanical stimulation induced by an acute hypotonic shock, a simple 87 way to experimentally activate Piezo channels. All chimeras displayed robust responses similar 88 to mPiezo1. These responses were significantly larger than the response obtained from cells 89 transfected with a control vector (Fig 1f) . 90
91
A minimal region for Yoda1 binding 92
To verify that the region 1961-2063 contains the molecular determinants for Yoda1 binding, we 93 created the internal chimera Ch1961-2063. We next divided this region into three sub-regions 94 (region 1: 1961-2004, region 2: 2005-2034 and region 3: 2035-2063) and engineered every 95 possible combination of "sub-chimeras" replacing one or two sub-regions by the corresponding 96 sequence from the mPiezo2 homolog (Fig 2a and Supplementary Fig 1) . 97
For simplicity, these sub-chimeras were named by the number of the sub-region(s) being 98
replaced (e.g. Ch1+3 in Fig 2a replaces showing GCaMP6m time course upon Yoda1 application in the presence or absence of mPiezo1 103 can be seen in Video1 and Video2, respectively. The fluorescence of GCaMP6m does not change 104 upon Yoda1 application in absence of mPiezo1, as when using Fluo8-AM (Fig 1d) . All tested 105 sub-chimeras displayed diminished fluorescence responses compared to mPiezo1 (Fig 2b) . Yet, 106 none of them completely suppressed the fluorescence response as seen in cells transfected with 107 mPiezo2 or with the internal chimera 1961-2063. The internal chimera 1961-2063 remains able 108 to elicit robust fluorescence responses upon acute hypotonic chock (Fig 2c) and to produce 109 mechano-dependent ionic currents with amplitude similar to wild type mPiezo1 (Fig 2d) . This 110
shows that the elimination of the fluorescence signal in cells transfected with Ch1961-2063 originates from the loss of the agonist binding site rather than a loss of channel function. We next 112 fitted the plots of the normalized peak currents I/I max against the pulse pressure P (Fig 2e) The presence of the entire mPiezo1 1961-2063 region appears necessary for chemical activation 122 with Yoda1. Interestingly, this region is strategically located at the interface between the pore 123 and the blade in each subunit (Fig 1a and Fig 2f) . Since this region exists in each of the three 124 
Assuming the existence of three identical and independent Yoda1 binding sites: 132
The different protein species are related by the corresponding macroscopic dissociation constant 133 K 1 , K 2 and K 3 corresponding to each binding step: 134
By replacing the macroscopic constants: 135
The macroscopic constants are related to the microscopic dissociation constant K d by the number 136 or possible binding combinations Ω n,i for each binding step i and for n binding sites: 137
Replacing the macroscopic constants by the K d gives: 138
Equation (6) further simplifies by applying a binomial reduction: 139
The details about this reduction can be found elsewhere(28). Assuming the binding of one or 140 more ligand per channel produces similar channel opening, every bound species in the numerator 141 of equation (6) contribute proportionally to the observed fluorescence signal: 142
However, if the binding of two or three ligands is required for channel activation, the fraction of 143 channel with a single ligand does not contribute to the signal. In this case, the fluorescence signal 144 follows: 145
Similarly, if the binding of three ligands is necessary for channel activation, the fluorescence 146 signal follows: 147
We tested these three binding situations modeled by equations (8), (9) and (10) by performing a 148 dose-response on WT mPiezo1 with more data points (Fig 3a) . Curve fitting clearly shows that a 149 model with 3 ligands per channel (equation (10)) or with more than 2 ligands (equation (9)) does 150 not fit well the data (Fig 3a and Table 1 ). In contrast, a model where every bound species equally 151 contribute to the signal (equation (8) species with a number of WT subunits ranging from 0 to 3 (Fig 3b) . Assuming WT and chimeric 161 subunits are expressed in proportion to the amount of transfected plasmid and assuming hybrid 162 channels are formed by random association of WT and chimeric subunits, the fraction (Fr) of 163 assembled channels with i WT subunits for a trimeric channels is given by the equation: 164
With f Ch and f WT the relative fractions of plasmids encoding chimeric and WT subunits, 165 respectively. 166
We transfected HEK293T cells with different plasmid mixtures containing 10%, 30%, 167 50% or 100% WT mPiezo1. The predicted fraction for each species and for each tested mixture 168 is indicated in Fig 3b . Surprisingly, cells transfected with a mixture containing only 10% WT 169 subunits produced robust fluorescence signals (Fig 3c) . Indeed, at saturating Yoda 170 concentrations, this signal amounts to approximately a third of the fluorescence signal observed 171 in cells transfected with 100% WT plasmids. When mixing 10% WT subunit with 90% chimeric 172 subunit, the predicted fraction of channels containing three WT subunits is only 0.1%, while the 173 large majority of WT subunits exist in channels containing two chimeric subunits (Fig 3b) . This 174 indicates that the presence of a single WT subunit is sufficient for chemical activation of the 175 channel with Yoda1. This observation is consistent with the fitting results from Fig 3a. 176
Next, we further performed a global fit of the dose-responses obtained for different 177 mixtures and for WT mPiezo1. Based on equations (8) and (11), the fluorescence signal from a 178 heterogeneous population of channel species with i number of WT subunit(s) will be a function 179 of the saturation fraction multiplied by the total relative fraction of channel species contributing 180 to the signal (i.e. having one or more WT subunit): 181
Since ∑ ( ) = = , the equation can be simplified: 182
Where Fr (i=0) correspond to the non-contributing fraction of channels containing three chimeric 183 subunits. Equation (12) In this study, we created chimeras between Piezo1 and Piezo2 to identify the minimal region 208 required for the selective binding of the agonist Yoda1. In principle, the Yoda1 binding site on 209
Piezo1 could be directly identified by solving the structure of the agonist-channel complex. 210 However, the current resolution of the mPiezo1 structure (4.8Å) is too low to resolve most side 211 chains in the protein. This would preclude the localization of the 21-atom Yoda1 molecule. On 212 the other hand, the agonist binding site could be identified in functioning Piezo1 channels using a 213 spectroscopic nanopositioning approach(29). However, such spectroscopic measurements would 214 require fluorescent versions of Yoda1 which retain the same pharmacological properties. 215
Our data show that the strict selectivity of Yoda1 towards mPiezo1 originates from a 216 minimal protein region spanning residues 1961 to 2063. This region contains 17 residues that are 217 not conserved between the two mammalian Piezo isoforms and that are dispersed into three 218 clusters ( Supplementary Fig 1) . The mPiezo1 channel becomes fully insensitive to Yoda1 only 219 when all three clusters are exchanged with their counterpart from the mPiezo2 primary sequence. 220 Any chimeric combination made by exchanging two out of three clusters yielded chimeras with 221 some degree of Yoda1 sensitivity (Fig 2b) . Thus, some, if not all, residues from each cluster are 222 required to form the Yoda1 binding site. We do not know yet whether Yoda1 directly interacts 223 with these residues or whether some of these residues are required to form a binding site in a 224 nearby region. Hence, we envisage two hypotheses to explain the origin of Yoda1 isoform-225 selectivity. First, Yoda1 may directly interact with Piezo1-specific residues. In this case, Yoda1 226 must directly interact with some of the identified residues in each cluster in the region 1961-227 2063. Second, Yoda1 may directly interact with residues that are conserved in Piezo1 and Piezo2 228 but whose conformation depends on the presence of non-conserved residues in each cluster in the 229 conformation of the binding site rather than from a difference in the chemical composition of its 231 residues. Future studies will be needed to distinguish between these two possibilities. 232
Activation of the Yoda1-insensitive Ch1961-2063 chimera by negative pressure in a cell-233 attached patch requires higher pressures than WT mPiezo1 channels (Fig 2e) . Incidentally, the 234 threshold for mechanical activation of mPiezo2 channels is also higher than for mPiezo1 (26) . 235
Hence, the region identified here as necessary for agonist binding appears as an important region 236 to regulate the mechanical sensitivity of Piezo channels. 237
The predicted fractions of hybrid channels obtained by mixing WT and mutant subunits 238 are true if only two assumptions are satisfied. The first is that the cellular expression of both 239 subunits is proportional to the quantity of transfected plasmid. This seems to be the case 240 according to the similar level of ionic current measured in cells transfected with the individual 241 plasmids (Fig 2d) . The other assumption is that both subunits randomly assemble to form 242 trimeric channels. We do not know if this is the case. Protein-protein interaction experiments 243 such as resonance energy transfer between fluorescent probes covalently linked to WT and 244 chimeric subunits would confirm the existence of hybrid channels. However, the absolute 245 quantification of the species in a heterogenous population of hybrid channels would be 246 technically challenging to assess. 247
The fact that a single WT subunit suffices to confer Yoda1 sensitivity to the trimeric 248 channel has profound mechanistic consequences regarding the gating process of the channel. create the polycistronic vector pCDNA3-mPZ1-IRES-GCaMP6m, we PCR-amplified the 271 pCDNA-mPZ1 plasmid, the internal ribosome entry site (IRES) cassette from a pIRES-eGFP 272 plasmid and the GCaMP6m cDNA from a pGP-CMV-GCaMP6m plasmid (Addgene plasmid 273 #40754) and assembled them using the NEBuilder HiFi DNA Assembly kit (New England 274 Biolabs). A similar procedure was used to create pCDNA3-mPZ2-IRES-GCaMP6m, pCDNA3-275
GCaMP6m and the empty control vector pCDNA3. All mPZ1-mPZ2 chimeras with or withouth 276 the IRES-GCaMP6m cassette were created using the same approach. All constructs were verified 277 by automated Sanger sequencing (Genewiz). 278
279
Cell culture and transfection: HEK293T cells (a gift from Dr. Mikhail Shapiro and originally 280 purchased directly from ATCC) were cultured in standard conditions (37°C, 5% CO 2 ) in a 281 DMEM medium supplemented with Penicillin (100 U/mL), streptomycin (0.1 mg/mL), 10% 282 sterile Fetal Bovine Serum and 1X MEM non-essential amino-acid without L-glutamine. All cell 283 culture products were purchased from Sigma-Aldrich. Transfection was done on cells with a 284 passage number lower than 25 using polyethylenimine (PEI, Polysciences #23966). Briefly, a 285 sterile mixture of DNA:PEI (1:4 w/w) was prepared using sterile 100mM NaCl solution and 286 added directly to the cell's culture medium (220ng of total DNA was added per cm 2 of cultured 287 surface). Culture medium was changed 16-20 hours after transfection. 
